PerkinElmer
check quantity

OsteoSense 800 Fluorescent Imaging Agent

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications. 

You successfully added item(s) to your cart

For laboratory use only. This product is intended for animal research only and not for use in humans.

Part Number
List Price
Your Price
Quantity
NEV11105
448.00 EUR
more
Buy Now

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Detail Information

OsteoSense® 800 is a targeted fluorescent in vivo bisphosphonate imaging agent. OsteoSense 800 images areas of microcalcifications and bone remodeling and enables imaging of bone growth and resorption. OsteoSense 800 fluorescent imaging agent at a wavelenth at 800 nm, can be used to measure the effects of therapeutic stimulation of bone growth. This agent can also be used to characterize bone remodeling associated with animal models of arthritis. OsteoSense 800 enables in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.

Specifications

Fluorescent Agent Type Targeted
Optical Imaging Classification Fluorescence Imaging
Product Brand Name OsteoSense
Quantity in a Package Amount 1.0 Units
Shipping Condition Ambient
Therapeutic Area Atherosclerosis, Arthritis, Oncology/Cancer
Unit Size 1 Vial (10 doses)
Wave Length 800 nm
Resources, Events & More
  • All

Poster

Imaging of Cathepsin K activity in rodent models of bone turnover and soft tissue calcification

Imaging of Cathepsin K activity in rodent models of bone turnover and soft tissue calcification

PDF 966 KB

Technical Note

OsteoSense 800 (Protocol)

Protocol for OsteoSense 800 targeted fluorescent in vivo imaging agent

PDF 215 KB
OsteoSense® 800 (Data Sheet)

OsteoSense® 800 is a fluorescent in vivo diphosphonate imaging agent. OsteoSense 800 images areas of microcalcification and bone remodeling and enables imaging of bone growth and resorption.

PDF 176 KB